Log ind Opret login

Karolinska appoints new CEO

Bruno Lucidi.jpg Top picks in English:

The replacement for Torbjørn Bjerke has been found two weeks after the Danish CEO was fired by Sweden’s Karolinska Development. The new chief has previously founded a biotech company that was sold to Merck in a billion-dollar deal recently.

Rebien: Novo-workers contribute or they are cast out

An employee’s level of commitment can be affected by circumstances in the family, such as disease – and the company should be sensitive to that. But if people are down-right uncommitted, the corporate culture is so strong that it will gradually expel them. Lars Rebien, at the peak of his career, spoke to Medwatch about the unique Novo spirit, about failing politicians, and about growing softer.